SCHEMBL7569645

SCHEMBL7569645

O=C1N=C(O)C(c2ccc(C3CCCCC3)cc2)=NC1Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.38
HSP90AA1 P07900 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CES2 O00748 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
HAO1 Q9UJM8 1/20 0.34
BDKRB2 P30411 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MMP2 P08253 1/20 0.34
MMP9 P14780 1/20 0.34
PDE2A O00408 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7571222 0.96 NPC1 (0.38) DHODHHSP90AA1GAAMAPTKMT2A
SCHEMBL7572458 0.84 BDKRB2 (0.42) CES2BDKRB2HDAC3HDAC1HDAC8
SCHEMBL7571381 0.83 HDAC3 (0.42) BDKRB2HDAC3HDAC1HDAC8HDAC6
SCHEMBL7571208 0.81 NPC1 (0.44) GAAMAPTCES2NPC1RAB9A
SCHEMBL7576544 0.81 CES2 (0.44) MAPTKMT2ACES2BDKRB2HDAC3
SCHEMBL7571711 0.81 CES2 (0.38) CES2BDKRB2HDAC3HDAC1HDAC8
SCHEMBL7572631 0.76 CES2 (0.42) GAACES2BDKRB2HDAC3HDAC1
SCHEMBL7572718 0.76 CES2 (0.43) MAPTKMT2ACES2BDKRB2HDAC3
SCHEMBL7570886 0.75 PSD (0.37) KMT2ATDP1NPC1RAB9ABDKRB2
SCHEMBL7570328 0.74 CES2 (0.45) CES2HDAC3HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085369-A1 INHIBITORS OF ANTHRAX LETHAL FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS, INC. (US) 2002-10-31 WO disclosed